Please assess the completion status of the following clinical trial:

Trial Title: Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CT

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically-proven newly diagnosis or recurrence as indicated by tissue diagnosis of T3 or T4 squamous cell carcinoma of the head and neck~* Must have had or be scheduled for standard-of-care surgical resection, radiation, and/or chemo-radiation of the diagnosed squamous cell carcinoma of the head and neck~* At least 18 years of age~* Patient must be able to understand and willing to sign a written informed consent document.~Exclusion Criteria:~* Contraindications to MRI, including:~  * MRI-incompatible implantable devices~ * severe claustrophobia; and~* Pregnant and/or breastfeeding, with women of childbearing potential having a negative urine or serum pregnancy test

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- DWI MRI + Standard of care FDG PET/CT (Type: EXPERIMENTAL): -The patients will undergo an optimized research neck DWI MRI, up to 3 weeks post-treatment and then a standard-of-care 3-month post-treatment FDG PET/CT examination.

Based on this trial design, predict the completion outcome and termination type (if applicable).